Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Extracellular Vesicles and Circulating Nucleic Acids|December 19, 2024
Inhibition of osteosarcoma by European Mistletoe derived val-miR218Wenyan Xie, Catharina Delebinski, Dennis Gürgen, et al.Scientific Reports|December 29, 2019
mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal CellsTheres Schaub, Dennis Gürgen, Deborah Maus, et al.Scientific Reports|February 27, 2020
Publisher Correction: mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal CellsTheres Schaub, Dennis Gürgen, Deborah Maus, et al.Communications Biology|January 18, 2022
Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenograftsDennis Gürgen, Theresia Conrad, Michael Becker, et al.Plos One|April 17, 2015
17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodelingAngelika Kusch, Maria Schmidt, Dennis Gürgen, et al.Hypertension (Dallas, Tex. : 1979)|January 23, 2013
Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt modelDennis Gürgen, Angelika Kusch, Robin Klewitz, et al.Hypertension (Dallas, Tex. : 1979)|February 9, 2011
Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt miceDennis Gürgen, Björn Hegner, Angelika Kusch, et al.Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphismAysun Karatas, Björn Hegner, Leon J de Windt, et al.Plos One|January 5, 2016
Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceYe Zhu, Maximilian Blum, Uwe Hoff, et al.Frontiers in Oncology|July 8, 2022
A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment StrategiesDennis Gürgen, Michael Becker, Mathias Dahlmann, et al.Pageof 3